Navigation Links
Report finds Big Pharma is doing more for access to medicine in developing countries
Date:11/28/2012

ore than 100 factors covering these areas, including whether they are developing new drugs for neglected diseases, to what extent they facilitate or resist efforts to create generic versions of their drugs, and how they approach pricing in developing countries. Lobbying activities, marketing ethics and product donations and other philanthropic activities are also tracked.

Ranking highlights: Who is doing the most?

GlaxoSmithKline remains at the top of the Index with a marginal improvement in performance since 2010, and this year, Johnson & Johnson and Sanofi, both new to the top three, follow closely in 2nd and 3rd positions respectively. The companies that rose in rank the most were Merck KGaA, followed by Johnson & Johnson, and then Bayer. AstraZeneca fell down the rankings most significantly, followed by Boehringer-Ingelheim, then Novartis and Roche. The bottom of the league is dominated by Japanese companies Takeda, Daiichi and Astellas.

Overall trends

Seventeen out of the 20 companies perform better than they did at the time of the last Index report in 2010. At the top end, membership of the leading group has expanded from three to seven companies, and there is a smaller difference between the scores of the Index leaders than there was in 2010. Meanwhile, the gap has also narrowed between the bottom few companies and the top performers. This is notable given the fact that the Index set higher standards this year in many areas.

Companies are developing more products for more diseases that particularly affect the world's poor, and collaborating more in the process than they were two years ago. There is more target setting and some now devote as much as 20% of their pipeline to developing products that address the needs of the poor. For instance, Sanofi is adapting its leishmaniasis drug, which currently requires health workers to administer repeated injections, to develop a product that patients can apply to thei
'/>"/>

Contact: Suzanne Wolf
swolf@atmindex.org
31-235-339-187
Access to Medicine Foundation
Source:Eurekalert  

Page: 1 2 3 4

Related medicine news :

1. 1 in 4 in U.S. Starts Drinking Before Turning 21: Report
2. Elsevier launches new open access journal -- Epilepsy & Behavior Case Reports
3. Elsevier launches new open access journal: Leukemia Research Reports
4. Device May Allow Blind to Read Braille Without Touch: Report
5. Annual Trouble in Toyland Report Cites Toy Dangers
6. CDC and NIH survey provides first report of state-level COPD prevalence
7. Teen Smoking Has Fallen Across Most of U.S.: Report
8. Researchers report potential new treatment to stop Alzheimers disease
9. More Americans Buckling Up Than Ever Before: Report
10. Black Women More Likely to Die From Breast Cancer: Report
11. U.S. Preterm Birth Rate Continues to Drop: Report
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Report finds Big Pharma is doing more for access to medicine in developing countries
(Date:1/22/2015)... 2015 Juvent Sports ( http://www.juventsports.com ) ... PGA Merchandise Show to bestow a Juvent Sports Achievement ... golfer, Arlene McKitrick. The award commemorated and congratulated McKitrick ... win. She won her first amateur tournament in 1979 ...
(Date:1/22/2015)... New York, New York (PRWEB) January 22, 2015 ... filed after Fresenius Medical Care recalled its GranuFlo ... the federal multidistrict litigation underway in U.S. District Court, ... an Order dated January 20th, the Court has remanded ...
(Date:1/22/2015)... 2015 For over 20 years, Dr. David Cruz ... Vista area has treated just about every type of injury ... And for those same twenty-plus years, the team at ... injuries with the best possible doctor. With the combined ...
(Date:1/22/2015)... January 22, 2015 Joan Lunden, award-winning ... speaker at the upcoming 32nd Annual Miami Breast ... Physicians’ Education Resource®, LLC (PER®) , shares that “a ... gone undetected if she had not followed up her ...
(Date:1/22/2015)... Jolla, Calif. (PRWEB) January 22, 2015 ... Assemblymembers Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) ... for their leadership in advancing biotechnology, biomedical science, ... Bonilla and Olsen each received the “2014 Life ...
Breaking Medicine News(10 mins):Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3
... discussed at the 2009 AANS MeetingATLANTA, April 30 ... Annual Meeting, May 4-6 at the San Diego Convention ... latest line of stereotactic treatment solutions is addressing some ... today. Local Control of Brain Mets , Recent ...
... would it take to walk across the United States? ... Carolina,s community events marking National Walk @ Lunch Day(R) ... estimated 3,000 people turned out for lunchtime community walks ... and Falls Park in Greenville, and together walked approximately ...
... Assisted Living, Home Care and Adult Day Health Care Costs ... The cost of long term care in Virginia ... pressure on those in or near retirement, according to an ... the current economic downturn has led to a decline in ...
... of disease in middle-age and beyond, study suggests , , WEDNESDAY, ... prevention should start much earlier in life than it currently ... in young women. , The study of 400 women, ... tissue composition in young women may be associated with their ...
... Living, Home Care and Adult Day Health Care Costs in ... The cost of long term care in Ohio is ... on those in or near retirement, according to an annual ... current economic downturn has led to a decline in home ...
... Access to Nursing Home, Assisted Living, Home Care and Adult ... Va., April 30 The cost of certain types of ... rate outpacing inflation, putting significant financial pressure on those in ... Financial. At the same time, the current economic downturn ...
Cached Medicine News:Health News:Elekta Radiosurgery Solutions are Creating New Possibilities for the Most Challenging Cases of the Head And Body 2Health News:Elekta Radiosurgery Solutions are Creating New Possibilities for the Most Challenging Cases of the Head And Body 3Health News:Columbia, Greenville, Charleston Walkers Cover 3,000 Miles During Lunch 2Health News:Growth in Virginia Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 2Health News:Growth in Virginia Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 3Health News:Growth in Virginia Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 4Health News:Young Women's Breast Tissue Offers Clues to Cancer Risk 2Health News:Growth in Ohio Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 2Health News:Growth in Ohio Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 3Health News:Growth in Ohio Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 4Health News:Growth in New Hampshire Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 2Health News:Growth in New Hampshire Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 3Health News:Growth in New Hampshire Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 4
(Date:1/23/2015)... , Jan. 23, 2015  Immune Therapeutics, Inc. today announced the ... the compounding, packaging and distributing of its naltrexone tablets.  The ... United States . KRS Global is ... tablets in various strengths for individual patients in response to ...
(Date:1/23/2015)... GAINESVILLE, Fla. , Jan. 23, 2015  HyGreen, Inc., ... distribution agreement and partnership with RCA Medical, a subsidiary ... Africa . Each year, hundreds of ... health care-associated infections as organisms are transmitted from patient ...
(Date:1/23/2015)... 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced that ... of Lixte,s lead compound, LB‑100, is being conducted, has been ... S. Kovach , M.D., the founder and President of Lixte, ... at a single site. Accrual of patients, however, was slower ...
Breaking Medicine Technology:Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
... Addrenex Pharmaceuticals today expanded its pipeline of ... of an agreement to license a new drug ... debilitating sleep disorder, as well as other neurologic ... Addrenex the worldwide rights (excluding East Asia) to ...
... Circassia Ltd, a specialty,biopharmaceutical company focused on allergy, ... clinical development programme for its ragweed allergy,therapy. The ... based on Circassia,s ToleroMune(R) technology, which has previously,achieved ... allergies. Ragweed,is one of the leading causes of ...
Cached Medicine Technology:Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy 2Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy 3Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy 2
Tryptone is the pancreatic digest of casein used as a nitrogen source for bacteria. Ideal for general bacteriological use with a variety of microorganisms. Tryptone is guaranteed BSE-Free....
... is a compact model that combines simultaneous ... ml tubes. Impressive features of the Thermomixer ... high stabilityeven at maximum mixing frequency. Product ... vigorous mixing, including intermittent mixing; operates from ...
Contains 5 mg of penicillin, 5 mg of streptomycin, and 10 mg of neomycin/ml utilizing penicillin G (sodium salt), streptomycin sulfate, and neomycin sulfate in 0.85% saline....
Penicillin-Streptomycin-Glutamine (100X) liquid...
Medicine Products: